Targeting Neuroinflammation to Treat Alzheimer’s Disease

Over the past few decades, research on Alzheimer’s disease (AD) has focused on pathomechanisms linked to two of the major pathological hallmarks of extracellular deposition of beta-amyloid peptides and intra-neuronal formation of neurofibrils. Recently, a third disease component, the neuroinflammato...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:CNS Drugs
Auteurs principaux: Ardura-Fabregat, A., Boddeke, E. W. G. M., Boza-Serrano, A., Brioschi, S., Castro-Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, Michael T., Hoeijmakers, L., Hoffmann, A., Iaccarino, L., Jahnert, S., Kuhbandner, K., Landreth, G., Lonnemann, N., Löschmann, P. A., McManus, R. M., Paulus, A., Reemst, K., Sanchez-Caro, J. M., Tiberi, A., Van der Perren, A., Vautheny, A., Venegas, C., Webers, A., Weydt, P., Wijasa, T. S., Xiang, X., Yang, Y.
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2017
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5747579/
https://ncbi.nlm.nih.gov/pubmed/29260466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-017-0483-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires